PridCor Therapeutics

Private

Tuscaloosa, AlabamaHealthcare & Life Scienceshttps://pridcor.com/

Last Round

Early Stage

May 8, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

PridCor Therapeutics is a clinical-stage biopharmaceutical company that develops novel antiviral therapies to address infection-associated chronic illnesses, including Long COVID and other viral-driven conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

Huntington's Disease treatmentALS treatmentpridopidineneurodegenerative disease treatmentSigma-1 Receptor agonistS1R agonistneuroprotective therapyfirst-in-class drugsmall molecule drugclinical stage pharmadrug developmentbiopharmaceutical companyoral drugpharmaceutical licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PridCor Therapeutics Comparables

Compare PridCor Therapeutics with similar companies based on industry and business-model similarity.

PridCor Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Spinogenix, Inc.	77%
NeuroSense Therapeutics	74%
Anavex Life Sciences	67%

View all Comparables

PridCor Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Early Stage VC	May 8, 2026

View all Funding Rounds

Key People

Founding team and executive leadership

William Pridgen

Chief Executive Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

May 8, 2026
Raised an Early Stage VC round.

View all signals

PridCor Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

PridCor Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PridCor Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersTuscaloosa, Alabama

Employee Range2

Year Founded2025

Last FundingMay 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.